Nana Wu

Pivot Point: Cellectis Abandons Allogeneic Cell Therapy Ambitions for Cardiovascular Gene Editing

• Treatment Innovations

Pivot Point: Cellectis Abandons Allogeneic Cell Therapy Ambitions for Cardiovascular Gene Editing

Nana Wu September 16, 2026

By Jonathan Gardner | Published September 14, 2026 In a decisive move that signals a fundamental retreat...

Read More Read more about Pivot Point: Cellectis Abandons Allogeneic Cell Therapy Ambitions for Cardiovascular Gene Editing

The Price of Uncertainty: Why Breast Reconstruction Costs Remain Hidden Despite Federal Transparency Mandates

• Breast Cancer Surgery and Reconstruction

The Price of Uncertainty: Why Breast Reconstruction Costs Remain Hidden Despite Federal Transparency Mandates

Nana Wu September 16, 2026

For patients navigating a breast cancer diagnosis, the medical journey is fraught with physical, emotional, and psychological...

Read More Read more about The Price of Uncertainty: Why Breast Reconstruction Costs Remain Hidden Despite Federal Transparency Mandates

The Architecture of Belonging: Why We Grieve When Our “Third Places” Shift

• Integrative Oncology and Holistic Care

The Architecture of Belonging: Why We Grieve When Our “Third Places” Shift

Nana Wu September 15, 2026

Published September 15, 2026 For the casual observer, a yoga studio relocation might appear as a logistical...

Read More Read more about The Architecture of Belonging: Why We Grieve When Our “Third Places” Shift

The Dawn of the In Vivo Revolution: How Next-Generation CAR-T Therapies Are Redefining Oncology

• Clinical Oncology Education

The Dawn of the In Vivo Revolution: How Next-Generation CAR-T Therapies Are Redefining Oncology

Nana Wu September 15, 2026

The landscape of cellular immunotherapy is undergoing a seismic shift. For over a decade, Chimeric Antigen Receptor...

Read More Read more about The Dawn of the In Vivo Revolution: How Next-Generation CAR-T Therapies Are Redefining Oncology

ERS 2026: oral IRAK4 inhibitor AZD6793 enters dose-ranging Phase IIb COPD trial

• Medical Research and Clinical Trials

ERS 2026: oral IRAK4 inhibitor AZD6793 enters dose-ranging Phase IIb COPD trial

Nana Wu September 14, 2026

To write a news article, I need actual news content, such as: Main Facts: Who, what, when,...

Read More Read more about ERS 2026: oral IRAK4 inhibitor AZD6793 enters dose-ranging Phase IIb COPD trial

Breakthrough Discovery Links Age-Related Blood Cell Mutations in Tumours to Worse Cancer Outcomes

• Medical Research and Clinical Trials

Breakthrough Discovery Links Age-Related Blood Cell Mutations in Tumours to Worse Cancer Outcomes

Nana Wu September 13, 2026

London, UK / New York, USA – A groundbreaking collaborative study has unveiled a critical connection between...

Read More Read more about Breakthrough Discovery Links Age-Related Blood Cell Mutations in Tumours to Worse Cancer Outcomes

The Hidden Determinant: How ‘Food Deserts’ Impact Recovery After Breast Reconstruction Surgery

• Breast Cancer Surgery and Reconstruction

The Hidden Determinant: How ‘Food Deserts’ Impact Recovery After Breast Reconstruction Surgery

Nana Wu September 12, 2026

For patients undergoing breast reconstruction following a mastectomy, the path to recovery is often viewed through the...

Read More Read more about The Hidden Determinant: How ‘Food Deserts’ Impact Recovery After Breast Reconstruction Surgery

Navigating Childhood Reactions: A Guide for Parents Facing Cancer

• Patient Advocacy and Support

Navigating Childhood Reactions: A Guide for Parents Facing Cancer

Nana Wu September 12, 2026

By Kelsey Mora, CCLS, LCPC, Chief Clinical Officer at Pickles Group and Author of The Dot Method:...

Read More Read more about Navigating Childhood Reactions: A Guide for Parents Facing Cancer

From Laboratory Bench to Bedside: How the Broad Institute is Redefining Modern Medicine

• Genomics and Precision Medicine

From Laboratory Bench to Bedside: How the Broad Institute is Redefining Modern Medicine

Nana Wu September 12, 2026

The landscape of modern medicine is currently undergoing a radical transformation, driven by an unprecedented convergence of...

Read More Read more about From Laboratory Bench to Bedside: How the Broad Institute is Redefining Modern Medicine

The Genomic Frontier: How the Broad Institute is Rewriting the Future of Medicine

• Genomics and Precision Medicine

The Genomic Frontier: How the Broad Institute is Rewriting the Future of Medicine

Nana Wu September 11, 2026

In the quiet, high-tech corridors of Cambridge, Massachusetts, a scientific revolution is unfolding. The Broad Institute of...

Read More Read more about The Genomic Frontier: How the Broad Institute is Rewriting the Future of Medicine